Financial News

Date Title and Summary Additional Formats
Toggle Summary ASTRO 2020 to Feature Latest MRIdian Clinical Experience Highlighting Outcomes in Tough to Treat Cancer
Nearly 40 MRIdian-focused presentations will be part of the ASTRO Scientific Sessions CLEVELAND , Oct. 21, 2020 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today that the company's MRIdian® Linac MRI-guided radiation therapy system will be featured at the 2020 Annual Meeting of the
Toggle Summary ViewRay Announces Conference Call for Third Quarter 2020 Financial Results to be Held After Market on November 5, 2020
CLEVELAND , Oct. 15, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its third quarter 2020 financial results.     ViewRay will hold a conference call to discuss results on Thursday, November 5, 2020 at 4:30 p.m. ET / 1:30 p.m. PT .
Toggle Summary Louis Stokes Cleveland VA Medical Center Purchases ViewRay's MRIdian Linac for MRI-Guided Radiation Therapy
MRIdian to Bring Benefits of MRI-Guided Radiation Therapy to Veterans Throughout Ohio and the Surrounding Region CLEVELAND , Oct. 14, 2020 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today that the Louis Stokes Cleveland VA Medical Center in Cleveland, Ohio has purchased the MRIdian ®
Toggle Summary ViewRay to Host Physician-led Webinar for Investors and Analysts at the 2020 American Society of Radiation Oncology (ASTRO) Annual Meeting
CLEVELAND , Oct. 1, 2020 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) today announced that the Company will host a virtual physician-led informational discussion for investors and analysts during the 2020 American Society of Radiation Oncology (ASTRO) Annual Meeting.
Toggle Summary Chungnam National University Sejong Hospital Begins Patient Treatments with ViewRay's MRIdian Linac
Brings Benefits of MRI-Guided Radiation Therapy Closer to Home for Cancer Patients in Korea CLEVELAND , Sept. 24, 2020 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today that Chungnam National University Sejong Hospital in Sejong, South Korea has begun patient treatments with the MRIdian
Toggle Summary ViewRay® to Participate in Upcoming Investor Conferences
CLEVELAND , Sept. 4, 2020 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced that the Company will participate in three upcoming virtual investor conferences.     Event :             Cantor Virtual Global Healthcare Conference   Format:   Virtual 1x1 Meetings Date:               
Toggle Summary 10,000th Patient Receives Treatment with ViewRay's MRIdian System
MRI-Guided Radiation Therapy Brings Cutting-Edge Cancer Treatment to Patients Around the World CLEVELAND , Sept. 1, 2020 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today that 10,000 patients have been treated to date using the company's MRIdian ® MRI-Guided Radiation Therapy System,
Toggle Summary ViewRay, GenesisCare and the University of Oxford Announce Groundbreaking Compassionate Access Programme Now Open to UK Patients with Localized Pancreatic Cancer
ViewRay, the GenesisCare Foundation and the Pancreatic Cancer Research Fund Work Together to Provide MRIdian Radiation Therapy at No Cost to NHS Pancreatic Cancer Patients CLEVELAND , Aug. 27, 2020 /PRNewswire/ --– ViewRay, Inc. (Nasdaq: VRAY) announced today that the GenesisCare Foundation's
Toggle Summary Dartmouth-Hitchcock Health Begins Patient Treatments with ViewRay's MRIdian Linac
Brings Benefits of MRI-Guided Radiation Therapy Closer to Home for Cancer Patients in New England CLEVELAND , Aug. 13, 2020 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today that Dartmouth-Hitchcock Health in New Hampshire has begun patient treatments with the MRIdian ® MRI-Guided
Toggle Summary Kaohsiung Medical University Chung-Ho Memorial Hospital Begins Patient Treatments with ViewRay's MRIdian Linac
First MR-Linac in Taiwan Provides Patients Access to MR-Guided Radiation Therapy CLEVELAND , Aug. 5, 2020 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today that Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH) in Kaohsiung City, Taiwan has begun patient treatments with the
Toggle Summary ViewRay Reports Second Quarter 2020 Results
CLEVELAND , July 30, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the second quarter ended June 30, 2020 .     Second Quarter 2020 Highlights: Total revenue of $14.2 million , primarily from two revenue units, compared to $30.2 million , primarily from
Toggle Summary ViewRay Announces Conference Call for Second Quarter 2020 Financial Results to be Held After Market on July 30, 2020
CLEVELAND , July 13, 2020 /PRNewswire/ --   ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its second quarter 2020 financial results.     ViewRay will hold a conference call to discuss results on Thursday, July 30, 2020 at 4:30 p.m. ET / 1:30 p.m. PT .
Toggle Summary ViewRay Announces 1-Year Outcomes on MR-Guided Radiation Treatment for Prostate Cancer Without Implanted Markers
Study Shows Low Incidence of Toxicity Using Stereotactic Body Radiation Therapy (SBRT) While Reducing Potential Complications Associated with Implanted Markers CLEVELAND , June 23, 2020 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today the publication by the European Urology Oncology
Toggle Summary ViewRay Announces Equity Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
CLEVELAND , June 3, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today grants of stock options and restricted stock units to Zach Stassen , Chief Financial Officer for the company.  These awards were granted as an inducement material to entering into employment with ViewRay , in
Toggle Summary ViewRay® to Present at the Jefferies 2020 Virtual Healthcare Conference
CLEVELAND , May 28, 2020 /PRNewswire/ --  ViewRay, Inc. (NASDAQ: VRAY) announced today that the Company will present at the Jefferies 2020 Virtual Healthcare Conference . Scott Drake , President and CEO, will participate in a fireside chat at 2:30 p.m. Eastern Time on Tuesday, June 2, 2020 .
Toggle Summary Providence Portland Medical Center Begins Patient Treatments with ViewRay's MRIdian Linac
First MR-Linac in the Pacific Northwest Expands Cancer Patients' Access to MR-Guided Radiation Therapy CLEVELAND , May 27, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that Providence Portland Medical Center in Portland, Oregon has begun patient treatments with the MRIdian®
Toggle Summary ViewRay Reports First Quarter 2020 Results
CLEVELAND , April 30, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the first quarter ended March 31, 2020 . First Quarter 2020 Highlights: Total revenue of $14.3 million , primarily from three revenue units including one system upgrade, compared to $20.3
Toggle Summary ViewRay Names Zach Stassen as Chief Financial Officer
CLEVELAND , April 30, 2020 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today that Zach Stassen has been named Chief Financial Officer, effective May 18, 2020 . Mr. Stassen will report directly to Scott Drake , President and Chief Executive Officer. Mr.
Toggle Summary ViewRay Announces Appointment of B. Kristine Johnson to its Board of Directors
CLEVELAND , April 16, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced the appointment of B. Kristine Johnson to its Board of Directors effective April 14, 2020 . Ms. Johnson brings a wealth of health care and medical technology knowledge, as well as broad experience in finance and
Toggle Summary ViewRay Announces Conference Call for First Quarter 2020 Financial Results to be Held After Market on April 30, 2020
CLEVELAND , April 9, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its first quarter 2020 financial results. ViewRay will hold a conference call to discuss results on Thursday, April 30, 2020 at 4:30 p.m. ET / 1:30 p.m. PT .

Stock Quote

Data Provided by Refinitiv. Minimum 15 minutes delayed.

E-mail Alerts

Alerts are e-mailed to you whenever certain new company information is posted to this site. Sign-up Now!
Click here for E-mail Alerts

Transfer Agent
American Stock Transfer & Trust Company, LLC
6201 15th Avenue
Brooklyn, NY 11219
(800) 937-5449
Website: www.amstock.com
Email: info@amstock.com

In Need of Customer Support? Contact

  Language Select